Stocklytics Platform
Asset logo for symbol BHAC
Barington/Hilco Acquisition
BHAC22
$10.580.00%$0.00
Asset logo for symbol BHAC
BHAC22

$10.58

0.00%

Performance History

Chart placeholder
Key Stats
Open$10.56
Prev. Close$0.00
EPS-0.25
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$72.37M
PE Ratio-
LOWHIGH
Day Range10.56
10.61
52 Week Range10.11
12.80
Ratios
Revenue-
EBITDA Margin %-
EPS-0.25

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Barington/Hilco Acquisition (BHAC)

Crixus BH3 Acquisition Company (BHAC) is a publicly-traded company that operates in the financial industry. The company specializes in the acquisition and management of various assets, including stocks and other financial instruments. BHAC has a long history of success, with a track record of delivering strong returns to its shareholders. The stock price history of BHAC shows a consistent upward trend over the years, reflecting the company's solid performance and market demand for its services.
As of the latest quote, BHAC stock is trading at a favorable price, making it an attractive investment opportunity. Moreover, recent news related to Crixus BH3 Acquisition Company indicates positive developments that could potentially drive the stock price even higher. Investors looking for a smart analysis of BHAC can rely on the company's strong fundamentals and its ability to generate consistent returns. BHAC's market cap is also noteworthy, making it a significant player in the financial industry.
Sector
Financial Services
Industry
Shell Companies
CEO
Mr. Gregory Freedman
Headquarters
Fort Lauderdale
Employees
0
Exchange
NASDAQ
add Barington/Hilco Acquisition to watchlist

Keep an eye on Barington/Hilco Acquisition

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Barington/Hilco Acquisition's (BHAC) price per share?

The current price per share for Barington/Hilco Acquisition (BHAC) is $10.58. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Barington/Hilco Acquisition (BHAC)?

For Barington/Hilco Acquisition (BHAC), the 52-week high is $12.8, which is 20.97% from the current price. The 52-week low is $10.11, the current price is 4.66% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Barington/Hilco Acquisition (BHAC) a growth stock?

Barington/Hilco Acquisition (BHAC) has shown an average price growth of -6.8% over the past three years. It has received a score of 52 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Barington/Hilco Acquisition as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Barington/Hilco Acquisition (BHAC) stock price performance year to date (YTD)?

As of the latest data, Barington/Hilco Acquisition (BHAC) has a year-to-date price change of 1.45%. Over the past month, the stock has experienced a price change of 1.94%. Over the last three months, the change has been -3.63%. Over the past six months, the figure is 0.01%.
help

Is Barington/Hilco Acquisition (BHAC) a profitable company?

Barington/Hilco Acquisition (BHAC) has a net income of $7.88M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$1.69M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of Barington/Hilco Acquisition (BHAC)?

Barington/Hilco Acquisition (BHAC) has a market capitalization of $72.37M. The average daily trading volume is 0, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level